Do critically ill patients benefit from GI bleeding prophylaxis (stress ulcer prophylaxis)? In the BMJ, a recent systematic review set out to assess the relative impact of proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), sucralfate, or no...
There is conjecture regarding a possible association between use of antipsychotic drugs and the development of venous thromboembolism (VTE). Researchers from the USA recently published research that compared the incidence of antipsychotic use in patients who developed...
Australian researchers have recently published data on an estimate of the prevalence of polypharmacy among Australians aged 70 years or more, spanning the years 2006–2017. Using data from a random 10% sample of Pharmaceutical Benefits Scheme (PBS) – the...
Recent research published in The Lancet has shone a light on the potential benefits of adding antiviral treatment to usual primary care for patients with influenza-like illness, seeking to determine if this approach reduces time to recovery overall, and for people in...
Concurrent use of NSAIDs with oral anticoagulants has conventionally been thought to confer an increased risk of bleeding, but data from the recently reported ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation;...
